Lu-177-DGUL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lu-177-DGUL, covering 2024-12-11 to 2024-12-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy [Phase 1, Phase 2]